U.S., Aug. 20 -- An application to own the trademark for 'AGOMAB' has been filed on Sep. 18, 2024.
Owner(s):
AgomAb Therapeutics NV; Posthoflei 1 /6, B-2600 Antwerp (Berchem), BELGIUM
Goods and/or Services:
For: Pharmaceutical and medical preparations for the treatment of fibrosis, fibrotic diseases, skin diseases, eye diseases, Lung diseases, Idiopathic pulmonary fibrosis, Interstitial lung disease, progressive pulmonary fibrosis, idiopathic pulmonary fibrosis, organ failure, liver disease, kidney disease, inflammatory disease, Inflammatory bowel disease, Crohn's disease, fibrostenosing Crohn's disease, Luminal Crohn's disease, Perianal Crohn's disease, Fistulizing Crohn's disease, ulcerative colitis, Intestinal cancer, Pulmonary arter...